
Women's Health Diagnostics
Description
Women's Health Diagnostics
Global Women`s Health Diagnostics Market to Reach $35.9 Billion by 2027
In the changed post COVID-19 business landscape, the global market for Women`s Health Diagnostics estimated at US$24.4 Billion in the year 2020, is projected to reach a revised size of US$35.9 Billion by 2027, growing at a CAGR of 5.7% over the analysis period 2020-2027. Breast Cancer Testing, one of the segments analyzed in the report, is projected to record a 7.2% CAGR and reach US$8.8 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Infectious Disease Testing segment is readjusted to a revised 4.7% CAGR for the next 7-year period.
The U.S. Market is Estimated at $6.7 Billion, While China is Forecast to Grow at 9.9% CAGR
The Women`s Health Diagnostics market in the U.S. is estimated at US$6.7 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$7.7 Billion by the year 2027 trailing a CAGR of 10.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.4% and 5.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$4.7 Billion by the year 2027.
Cervical Cancer Testing Segment to Record 5.9% CAGR
In the global Cervical Cancer Testing segment, USA, Canada, Japan, China and Europe will drive the 5.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$2.9 Billion in the year 2020 will reach a projected size of US$4.3 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Latin America will expand at a 7.2% CAGR through the analysis period.
The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.
Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.
Global Women`s Health Diagnostics Market to Reach $35.9 Billion by 2027
In the changed post COVID-19 business landscape, the global market for Women`s Health Diagnostics estimated at US$24.4 Billion in the year 2020, is projected to reach a revised size of US$35.9 Billion by 2027, growing at a CAGR of 5.7% over the analysis period 2020-2027. Breast Cancer Testing, one of the segments analyzed in the report, is projected to record a 7.2% CAGR and reach US$8.8 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Infectious Disease Testing segment is readjusted to a revised 4.7% CAGR for the next 7-year period.
The U.S. Market is Estimated at $6.7 Billion, While China is Forecast to Grow at 9.9% CAGR
The Women`s Health Diagnostics market in the U.S. is estimated at US$6.7 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$7.7 Billion by the year 2027 trailing a CAGR of 10.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.4% and 5.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$4.7 Billion by the year 2027.
Cervical Cancer Testing Segment to Record 5.9% CAGR
In the global Cervical Cancer Testing segment, USA, Canada, Japan, China and Europe will drive the 5.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$2.9 Billion in the year 2020 will reach a projected size of US$4.3 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Latin America will expand at a 7.2% CAGR through the analysis period.
Select Competitors (Total 41 Featured) -
- Abbott Laboratories, Inc.
- Alere, Inc.
- Becton, Dickinson and Company
- bioMerieux SA
- F. Hoffmann-La Roche AG
- GE Healthcare
- Hologic, Inc.
- Koninklijke Philips NV
- PerkinElmer, Inc.
- Quest Diagnostics, Inc.
- Siemens AG
The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.
Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.
Table of Contents
173 Pages
- I. METHODOLOGY
- II. EXECUTIVE SUMMARY
- 1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Women's Health Diagnostics – Global Key Competitors Percentage Market Share in 2022 (E)
- Impact of Covid-19 and a Looming Global Recession
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
- 2. FOCUS ON SELECT PLAYERS
- 3. MARKET TRENDS & DRIVERS
- 4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Recent Past, Current & Future Analysis for Women's Health Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
- TABLE 2: World Historic Review for Women's Health Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 3: World 15-Year Perspective for Women's Health Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2021 & 2027
- TABLE 4: World Recent Past, Current & Future Analysis for Breast Cancer Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
- TABLE 5: World Historic Review for Breast Cancer Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 6: World 15-Year Perspective for Breast Cancer Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
- TABLE 7: World Recent Past, Current & Future Analysis for Osteoporosis Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
- TABLE 8: World Historic Review for Osteoporosis Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 9: World 15-Year Perspective for Osteoporosis Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
- TABLE 10: World Recent Past, Current & Future Analysis for Ovarian Cancer Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
- TABLE 11: World Historic Review for Ovarian Cancer Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 12: World 15-Year Perspective for Ovarian Cancer Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
- TABLE 13: World Recent Past, Current & Future Analysis for Cervical Cancer Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
- TABLE 14: World Historic Review for Cervical Cancer Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 15: World 15-Year Perspective for Cervical Cancer Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
- TABLE 16: World Recent Past, Current & Future Analysis for Genetic Screening and Carrier Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
- TABLE 17: World Historic Review for Genetic Screening and Carrier Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 18: World 15-Year Perspective for Genetic Screening and Carrier Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
- TABLE 19: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
- TABLE 20: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 21: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
- TABLE 22: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
- TABLE 23: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 24: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
- TABLE 25: World Recent Past, Current & Future Analysis for Diagnostic & Imaging Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
- TABLE 26: World Historic Review for Diagnostic & Imaging Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 27: World 15-Year Perspective for Diagnostic & Imaging Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
- TABLE 28: World Recent Past, Current & Future Analysis for Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
- TABLE 29: World Historic Review for Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 30: World 15-Year Perspective for Home Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
- TABLE 31: World Women's Health Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2012 through 2027
- III. MARKET ANALYSIS
- UNITED STATES
- Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
- TABLE 32: USA Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 33: USA Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 34: USA 15-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications for the Years 2012, 2021 & 2027
- TABLE 35: USA Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 36: USA Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 37: USA 15-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2012, 2021 & 2027
- CANADA
- TABLE 38: Canada Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 39: Canada Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 40: Canada 15-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications for the Years 2012, 2021 & 2027
- TABLE 41: Canada Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 42: Canada Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 43: Canada 15-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2012, 2021 & 2027
- JAPAN
- Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
- TABLE 44: Japan Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 45: Japan Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 46: Japan 15-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications for the Years 2012, 2021 & 2027
- TABLE 47: Japan Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 48: Japan Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 49: Japan 15-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2012, 2021 & 2027
- CHINA
- Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
- TABLE 50: China Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 51: China Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 52: China 15-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications for the Years 2012, 2021 & 2027
- TABLE 53: China Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 54: China Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 55: China 15-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2012, 2021 & 2027
- EUROPE
- Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
- TABLE 56: Europe Recent Past, Current & Future Analysis for Women's Health Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
- TABLE 57: Europe Historic Review for Women's Health Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 58: Europe 15-Year Perspective for Women's Health Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2021 & 2027
- TABLE 59: Europe Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 60: Europe Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 61: Europe 15-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications for the Years 2012, 2021 & 2027
- TABLE 62: Europe Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 63: Europe Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 64: Europe 15-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2012, 2021 & 2027
- FRANCE
- Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
- TABLE 65: France Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 66: France Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 67: France 15-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications for the Years 2012, 2021 & 2027
- TABLE 68: France Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 69: France Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 70: France 15-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2012, 2021 & 2027
- GERMANY
- Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
- TABLE 71: Germany Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 72: Germany Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 73: Germany 15-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications for the Years 2012, 2021 & 2027
- TABLE 74: Germany Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 75: Germany Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 76: Germany 15-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2012, 2021 & 2027
- ITALY
- TABLE 77: Italy Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 78: Italy Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 79: Italy 15-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications for the Years 2012, 2021 & 2027
- TABLE 80: Italy Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 81: Italy Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 82: Italy 15-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2012, 2021 & 2027
- UNITED KINGDOM
- Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
- TABLE 83: UK Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 84: UK Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 85: UK 15-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications for the Years 2012, 2021 & 2027
- TABLE 86: UK Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 87: UK Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 88: UK 15-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2012, 2021 & 2027
- SPAIN
- TABLE 89: Spain Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 90: Spain Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 91: Spain 15-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications for the Years 2012, 2021 & 2027
- TABLE 92: Spain Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 93: Spain Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 94: Spain 15-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2012, 2021 & 2027
- RUSSIA
- TABLE 95: Russia Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 96: Russia Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 97: Russia 15-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications for the Years 2012, 2021 & 2027
- TABLE 98: Russia Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 99: Russia Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 100: Russia 15-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2012, 2021 & 2027
- REST OF EUROPE
- TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 102: Rest of Europe Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 103: Rest of Europe 15-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications for the Years 2012, 2021 & 2027
- TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 105: Rest of Europe Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 106: Rest of Europe 15-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2012, 2021 & 2027
- ASIA-PACIFIC
- Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
- TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Women's Health Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
- TABLE 108: Asia-Pacific Historic Review for Women's Health Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 109: Asia-Pacific 15-Year Perspective for Women's Health Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2021 & 2027
- TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 111: Asia-Pacific Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 112: Asia-Pacific 15-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications for the Years 2012, 2021 & 2027
- TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 114: Asia-Pacific Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 115: Asia-Pacific 15-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2012, 2021 & 2027
- AUSTRALIA
- Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2022 (E)
- TABLE 116: Australia Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 117: Australia Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 118: Australia 15-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications for the Years 2012, 2021 & 2027
- TABLE 119: Australia Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 120: Australia Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 121: Australia 15-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2012, 2021 & 2027
- INDIA
- Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2022 (E)
- TABLE 122: India Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 123: India Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 124: India 15-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications for the Years 2012, 2021 & 2027
- TABLE 125: India Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 126: India Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 127: India 15-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2012, 2021 & 2027
- SOUTH KOREA
- TABLE 128: South Korea Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 129: South Korea Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 130: South Korea 15-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications for the Years 2012, 2021 & 2027
- TABLE 131: South Korea Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 132: South Korea Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 133: South Korea 15-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2012, 2021 & 2027
- REST OF ASIA-PACIFIC
- TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 135: Rest of Asia-Pacific Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 136: Rest of Asia-Pacific 15-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications for the Years 2012, 2021 & 2027
- TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 138: Rest of Asia-Pacific Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 139: Rest of Asia-Pacific 15-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2012, 2021 & 2027
- LATIN AMERICA
- Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E)
- TABLE 140: Latin America Recent Past, Current & Future Analysis for Women's Health Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
- TABLE 141: Latin America Historic Review for Women's Health Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 142: Latin America 15-Year Perspective for Women's Health Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2021 & 2027
- TABLE 143: Latin America Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 144: Latin America Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 145: Latin America 15-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications for the Years 2012, 2021 & 2027
- TABLE 146: Latin America Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 147: Latin America Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 148: Latin America 15-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2012, 2021 & 2027
- ARGENTINA
- TABLE 149: Argentina Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 150: Argentina Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 151: Argentina 15-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications for the Years 2012, 2021 & 2027
- TABLE 152: Argentina Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 153: Argentina Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 154: Argentina 15-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2012, 2021 & 2027
- BRAZIL
- TABLE 155: Brazil Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 156: Brazil Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 157: Brazil 15-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications for the Years 2012, 2021 & 2027
- TABLE 158: Brazil Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 159: Brazil Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 160: Brazil 15-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2012, 2021 & 2027
- MEXICO
- TABLE 161: Mexico Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 162: Mexico Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 163: Mexico 15-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications for the Years 2012, 2021 & 2027
- TABLE 164: Mexico Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 165: Mexico Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 166: Mexico 15-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2012, 2021 & 2027
- REST OF LATIN AMERICA
- TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 168: Rest of Latin America Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 169: Rest of Latin America 15-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications for the Years 2012, 2021 & 2027
- TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 171: Rest of Latin America Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 172: Rest of Latin America 15-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2012, 2021 & 2027
- MIDDLE EAST
- Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2022 (E)
- TABLE 173: Middle East Recent Past, Current & Future Analysis for Women's Health Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
- TABLE 174: Middle East Historic Review for Women's Health Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 175: Middle East 15-Year Perspective for Women's Health Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2021 & 2027
- TABLE 176: Middle East Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 177: Middle East Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 178: Middle East 15-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications for the Years 2012, 2021 & 2027
- TABLE 179: Middle East Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 180: Middle East Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 181: Middle East 15-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2012, 2021 & 2027
- IRAN
- TABLE 182: Iran Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 183: Iran Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 184: Iran 15-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications for the Years 2012, 2021 & 2027
- TABLE 185: Iran Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 186: Iran Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 187: Iran 15-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2012, 2021 & 2027
- ISRAEL
- TABLE 188: Israel Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 189: Israel Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 190: Israel 15-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications for the Years 2012, 2021 & 2027
- TABLE 191: Israel Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 192: Israel Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 193: Israel 15-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2012, 2021 & 2027
- SAUDI ARABIA
- TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 195: Saudi Arabia Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 196: Saudi Arabia 15-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications for the Years 2012, 2021 & 2027
- TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 198: Saudi Arabia Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 199: Saudi Arabia 15-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2012, 2021 & 2027
- UNITED ARAB EMIRATES
- TABLE 200: UAE Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 201: UAE Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 202: UAE 15-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications for the Years 2012, 2021 & 2027
- TABLE 203: UAE Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 204: UAE Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 205: UAE 15-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2012, 2021 & 2027
- REST OF MIDDLE EAST
- TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 207: Rest of Middle East Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 208: Rest of Middle East 15-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications for the Years 2012, 2021 & 2027
- TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 210: Rest of Middle East Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 211: Rest of Middle East 15-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2012, 2021 & 2027
- AFRICA
- Women's Health Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2022 (E)
- TABLE 212: Africa Recent Past, Current & Future Analysis for Women's Health Diagnostics by Application - Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 213: Africa Historic Review for Women's Health Diagnostics by Application - Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 214: Africa 15-Year Perspective for Women's Health Diagnostics by Application - Percentage Breakdown of Value Sales for Breast Cancer Testing, Osteoporosis Testing, Ovarian Cancer Testing, Cervical Cancer Testing, Genetic Screening and Carrier Testing and Other Applications for the Years 2012, 2021 & 2027
- TABLE 215: Africa Recent Past, Current & Future Analysis for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
- TABLE 216: Africa Historic Review for Women's Health Diagnostics by End-Use - Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
- TABLE 217: Africa 15-Year Perspective for Women's Health Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Diagnostic & Imaging Centers and Home Care for the Years 2012, 2021 & 2027
- IV. COMPETITION
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.